title: Research activities to improve the utilization of antibiotics in Africa.
abstract: There is a need to improve the rational use of antibiotics across continents including Africa. This has resulted in initiatives in Botswana including treatment guidelines and the instigation of Antibiotic Stewardship Programs (ASPs). The next steps involve a greater understanding of current antibiotic utilization and resistance patterns (AMR). This resulted in a 2-day meeting involving key stakeholders principally from Botswana to discuss key issues including AMR rates as well as ASPs in both the public and private sectors. Following this, the findings will be used to plan future studies across Africa including point prevalence studies. The findings will be presented in July 2016 at the next Medicines Utilization Research in Africa meeting will ideally serve as a basis for planning future pertinent interventional studies to enhance the rational use of antibiotics in Botswana and wider.
authors.affiliation: a Department of Clinical Pharmacology , School of Medicine, University of Botswana , Gaborone , Botswana.
authors.forename: Amos
authors.initials: A
authors.lastname: Massele
authors.affiliation: b Ministry of Health, Nelson Mandela Drive , Gaborone , Botswana.
authors.forename: Celda
authors.initials: C
authors.lastname: Tiroyakgosi
authors.affiliation: c Managed Care, AFA , Gaborone , Botswana.
authors.forename: Matshediso
authors.initials: M
authors.lastname: Matome
authors.affiliation: d WHO Regional Office for Africa , Brazzaville , Republic of Congo.
authors.forename: Abayneh
authors.initials: A
authors.lastname: Desta
authors.affiliation: e WHO Headquarters , Geneva , Switzerland.
authors.forename: Arno
authors.initials: A
authors.lastname: Muller
authors.affiliation: f Department of Pharmacy , Nyangabgwe Hospital , Francistown , Botswana.|g University of South Africa , Pretoria , South Africa.
authors.forename: Bene D Anand
authors.initials: BD
authors.lastname: Paramadhas
authors.affiliation: h Bokamoso Private Hospital , Mmopane , Botswana.
authors.forename: Brighid
authors.initials: B
authors.lastname: Malone
authors.affiliation: h Bokamoso Private Hospital , Mmopane , Botswana.
authors.forename: Gobuiwang
authors.initials: G
authors.lastname: Kurusa
authors.affiliation: i Gaborone Private Hospital , Gaborone , Botswana.
authors.forename: Thatayaone
authors.initials: T
authors.lastname: Didimalang
authors.affiliation: i Gaborone Private Hospital , Gaborone , Botswana.
authors.forename: Mosana
authors.initials: M
authors.lastname: Moyo
authors.affiliation: j Department of Laboratory Medicine, Division of Clinical Pharmacology , Karolinska Institutet, Karolinska University Hospital Huddinge , Stockholm , Sweden.|k Strathclyde Institute of Pharmacy and Biomedical Sciences , University of Strathclyde , Glasgow , UK.
authors.forename: Brian
authors.initials: B
authors.lastname: Godman
mesh_terms: D000349:Africa; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001902:Botswana; D024881:Drug Resistance, Bacterial; D006801:Humans; D017410:Practice Guidelines as Topic; D012106:Research / Q000458:organization & administration*
chemical_list: D000900:Anti-Bacterial Agents
keywords: Africa; Antibiotics; Botswana; MURIA; rational use